Postgrad Med J

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Postgraduate Medical Journal 2008;84:57-59; doi:10.1136/pgmj.2007.064162
Copyright © 2008 The Fellowship of Postgraduate Medicine

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Papatsoris, A. G
Right arrow Articles by Anagnostopoulos, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Papatsoris, A. G
Right arrow Articles by Anagnostopoulos, F.

EDITORIAL

Men’s behaviour towards prostate cancer screening

Athanasios G Papatsoris 1, Fotios Anagnostopoulos 2

1 Department of Urology, Barts & The London NHS Trust, London, UK
2 Department of Psychology, Panteion University of Social & Political Sciences, Athens, Greece

Correspondence to:
Dr A G Papatsoris, Department of Urology, Barts & The London NHS Trust, London, UK; agpapatsoris@yahoo.gr

Keywords: behaviour; prostate cancer; screening

The first 150 words of the full text of this article appear below.

Prostate cancer remains the most common non-cutaneous malignancy in the Western world and is the second leading cause of cancer death in males.1 The lifetime risk of developing and dying from prostate cancer rises substantially among men after the age of 50 years and a twofold greater risk exists among African–American men. Along with age and race, having a family history of prostate cancer is also a well-established risk factor. The incidence of prostate cancer has increased dramatically within the past decade, primarily due to the utilisation of serum prostate specific antigen (PSA) as a screening test that has resulted in earlier diagnosis.1 Prostate cancer screening means the examination of asymptomatic people in order to classify them according to whether they are likely or unlikely to have prostate cancer. Apart from PSA, screening includes digital rectal examination, trans-rectal ultrasound and biopsies on indication.


PROBLEMS WITH ROUTINE SCREENING
Several problems have beset the widespread acceptance . . . [Full text of this article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 The Fellowship of Postgraduate Medicine